Dianthus Therapeutics
Associate Director, Early Commercial Strategy & Insights
Be an Early Applicant
Lead commercial insights and competitive intelligence for DNTH212 and claseprubart across autoimmune and rare indications. Build forecasting models, synthesize multi-source data into strategic recommendations, support lifecycle planning, indication prioritization, and commercial narratives. Partner with cross-functional teams and present findings to leadership to inform development and commercialization decisions.
About Us
We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology – enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation – enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections. To learn more, please visit www.dianthustx.com and follow us on LinkedIn.
About the Role
The Associate Director, Early Commercial Strategy and Insights will be responsible for helping to develop and execute the commercial insights strategy for Dianthus’ programs, DNTH212 and clauseprubart, across multiple autoimmune and rare disease indications. This includes generating actionable market insights, competitive intelligence, forecasting, and strategic recommendations to support development and commercialization planning for DNTH212 in SLE, Sjögrens syndrome, and Dermatomyositis, as well as claseprubart in Myasthenia Gravis (MG), Chronic Inflammatory, Demyelinating Polyneuropathy (CIDP), and Mutifocal Motor Neuropathy (MMN).
Reporting to the Senior Director, you will be a key member of a growing commercial organization, partnering closely with cross functional teams to shape development strategy, assess market opportunities, and support critical business decisions across both programs.
We are building a culture of individuals who hold our core principles at the center of our operations, with the goal to elevate the care of our patients’ lives. We are open to you working remotely.
Key Responsibilities
- Lead competitive intelligence related to the DNTH212 program – providing relevant and timely information to both the DNTH212 project team and to Dianthus leadership.
- Develop and execute a plan to develop a solid understanding of the dynamics underlying key potential markets, including pipeline development, current treatment and likely positioning of future treatments.
- Lead development of well-built and fact-based forecasting models for each indication.
- Work with the commercial and cross-functional project team to build out the commercial narratives around claseprubart and DNTH212– aimed at investors, patients and physicians
- Support lifecycle planning, indication prioritization, and portfolio strategy for both DNTH 212 and claseprubart.
- Contribute to market insights development for claseprubart and take part in building out the market insights function at Dianthus
Experience
- Bachelor’s degree is required. Advanced degree in life-sciences is strongly preferred. Must have substantial education in a field relevant to medicine
- Experience with rheumatology and/or neurology is strongly preferred
- Experience and proficiency analyzing and synthesizing data and information from multiple sources to create a clear and concise story is required
- Must have strong communication skills and comfort with presentation to executive leadership
- Experience conducting market research – including development of surveys, study-guides etc. is required
- Proficiency with MS Excel and experience building forecasts is required
- Experience with claims data analysis and/or EHR analysis preferred
- Experience conducting/moderating KOL interviews strongly preferred
Similar Jobs
Big Data • Food • Hardware • Machine Learning • Retail • Automation • Manufacturing
Lead strategy, engineering, and lifecycle management for enterprise directory and machine identity platforms. Own Active Directory, Entra ID, PKI/CLM (e.g., Venafi), HSMs, hybrid identity integrations, automation/IaC, resilience, and governance while driving platform roadmaps, modernizations, and cross-functional IAM collaboration.
Top Skills:
Active DirectoryAPIsAzureCertificate Lifecycle ManagementDevsecopsDnsEntra IdGroup PolicyHsmIdentity FederationIdentity SynchronizationInfrastructure As Code (Iac)Microsoft Entra IdPkiSaaSScriptingVenafi
Biotech
Drive new client acquisition and revenue through high-volume lead outreach, sales strategy, CRM pipeline management, client pitches, stakeholder engagement, pricing analysis, and cross-functional collaboration to meet sales targets.
Top Skills:
Ai ToolsCRM
Artificial Intelligence • Fintech • Insurance • Marketing Tech • Software • Analytics
Handle inbound insurance sales calls and warm leads, assess customer needs, recommend Property & Casualty coverages, close policy sales, complete paid licensing/training, follow set schedules, and meet performance and quality expectations in a remote workspace.
What you need to know about the NYC Tech Scene
As the undisputed financial capital of the world, New York City is an epicenter of startup funding activity. The city has a thriving fintech scene and is a major player in verticals ranging from AI to biotech, cybersecurity and digital media. It also has universities like NYU, Columbia and Cornell Tech attracting students and researchers from across the globe, providing the ecosystem with a constant influx of world-class talent. And its East Coast location and three international airports make it a perfect spot for European companies establishing a foothold in the United States.
Key Facts About NYC Tech
- Number of Tech Workers: 549,200; 6% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Capgemini, Bloomberg, IBM, Spotify
- Key Industries: Artificial intelligence, Fintech
- Funding Landscape: $25.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Greycroft, Thrive Capital, Union Square Ventures, FirstMark Capital, Tiger Global Management, Tribeca Venture Partners, Insight Partners, Two Sigma Ventures
- Research Centers and Universities: Columbia University, New York University, Fordham University, CUNY, AI Now Institute, Flatiron Institute, C.N. Yang Institute for Theoretical Physics, NASA Space Radiation Laboratory
